Latest News about NVS
Recent news which mentions NVS
From Benzinga
Novartis' STAMP Inhibitor Under FDA Review For Myeloid Leukemia
August 25, 2021
Tickers
NVS
From Benzinga
From Benzinga
Could Veeva Systems Stock Help You Retire a Millionaire?
August 21, 2021
From Motley Fool
From Benzinga
From MarketWatch
WHO-Led Study To Test Three Anti-Inflammatory Drugs For COVID-19
August 11, 2021
From Benzinga
Here Are the Winners of Cowen's Big Pharma R&D Showdown
August 07, 2021
From Motley Fool
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
From Benzinga
Tilray Stock Makes Profit, Crowd Goes Wild!
August 02, 2021
From InvestorPlace
Cannabis Movers & Shakers: BioHarvest Sciences, Green Hygienics, Realm of Caring, Media Central Corp, Al Harrington's Viola
August 02, 2021
From Benzinga
From Benzinga
Why XOMA Stock Is Trading Higher Wednesday?
July 28, 2021
From Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
From Benzinga
From InvestorPlace
From Benzinga
Earnings Scheduled For July 21, 2021
July 21, 2021
From Benzinga
From Benzinga
Rebound from Monday’s rout continues with Dow futures up 200 points and European equities higher
July 21, 2021
From MarketWatch
2 Compelling Reasons to Buy This Reawakened Pharma Giant
July 19, 2021
From Motley Fool
From InvestorPlace
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
July 15, 2021
From Benzinga
Incyte's Ruxolitinib Shows Better Outcomes Regardless Of Organs Affected In GvHD Patients
July 15, 2021
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
